Atlas Trials

Feasibility Study of Personalized Ultra-fractionated Stereotactic Ablative Radiotherapy (PULSAR) for Cancers of the Central Lung

Clinical trial NCT06712745 · RECRUITING

Trial details

NCT number
NCT06712745
Sponsor
University of Texas Southwestern Medical Center
Status
RECRUITING
Phase
Early Phase 1
Study type
INTERVENTIONAL
Cancer, LungMetastasis
Start date
2025-09-19
Primary completion
2028-12-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.